Allocation of IPO Proceeds to Capital Investment, IT, Hiring and Research and Development
First written in FY2019. 1 of 3 entries say "Restated". Latest entry: FY2022.
CellSource moved to the "Worse" side of this theme in 2023, 2 years before the typical company in this theme (2025).
14 other companies' latest entry also says "Reframed".
- FY2022ReframedAnnual report
「Of the funds raised at the time of the Company's listing on the Tokyo Stock Exchange Mothers market on 28 October 2019, now the Tokyo Stock Exchange Growth Market, the Company changed part of the planned uses and timing of the funds for the following reasons.」
The uses and timing of the funds raised through the listing were reviewed and reallocated to capital expenditures of ¥84.930 million, recruitment and personnel costs of ¥712.797 million, research and development expenses of ¥81.978 million, and other purposes. - FY2020RestatedAnnual report
「The funds raised through the public offering and other offerings conducted at the time of the stock listing are planned to be used for capital expenditures to expand facilities in preparation for future business expansion, expenditure on software and other enhancements, personnel and recruitment costs, and academic conference operating expenses and research and development expenses in the regenerative medicine-related business.」
The plan to use funds raised through the listing for facilities, IT, personnel, academic conference operations and research and development was reiterated. - FY2019First statedAnnual report
「The funds raised through the public offering conducted at the time of the stock listing are planned to be used for capital expenditures to expand facilities in preparation for future business expansion, expenditure on software and other enhancements, personnel and recruitment costs, and academic conference operating expenses and research and development expenses in the regenerative medicine-related business.」
The Company lists specific uses for the funds raised through the listing and also discloses that these uses may change due to changes in the business environment and strategy.